Clinical Trial Update: Safety Study of Dantrolene in Subarachnoid Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 safety study of dantrolene in patients with subarachnoid hemorrhage was completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Subarachnoid Hemorrhage

Drugs mentioned

• Dantrolene (dantrolene)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-05